It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Loss of function mutations of the chorein-encoding gene VPS13A lead to chorea-acanthocytosis (ChAc), a neurodegenerative disorder with accelerated suicidal neuronal cell death, which could be reversed by lithium. Chorein upregulates the serum and glucocorticoid inducible kinase SGK1. Targets of SGK1 include the Na+/K+-ATPase, a pump required for cell survival. To explore whether chorein-deficiency affects Na+/K+ pump capacity, cortical neurons were differentiated from iPSCs generated from fibroblasts of ChAc patients and healthy volunteers. Na+/K+ pump capacity was estimated from K+-induced whole cell outward current (pump capacity). As a result, the pump capacity was completely abolished in the presence of Na+/K+ pump-inhibitor ouabain (100 µM), was significantly smaller in ChAc neurons than in control neurons, and was significantly increased in ChAc neurons by lithium treatment (24 hours 2 mM). The effect of lithium was reversed by SGK1-inhibitor GSK650394 (24 h 10 µM). Transmembrane potential (Vm) was significantly less negative in ChAc neurons than in control neurons, and was significantly increased in ChAc neurons by lithium treatment (2 mM, 24 hours). The effect of lithium on Vm was virtually abrogated by ouabain. Na+/K+ α1-subunit transcript levels and protein abundance were significantly lower in ChAc neurons than in control neurons, an effect reversed by lithium treatment (2 mM, 24 hours). In conclusion, consequences of chorein deficiency in ChAc include impaired Na+/K+ pump capacity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 University of Leipzig, Paul Flechsig Institute of Brain Research, Leipzig, Germany (GRID:grid.9647.c) (ISNI:0000 0004 7669 9786); University of Tübingen, Department of Ophthalmology, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
2 German Center for Neurodegenerative Diseases, Tübingen, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); University of Tübingen, Department of Neurology and Hertie Institute for Clinical Brain Research, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
3 University of Tübingen, Medical Genetics and Applied Genomics, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
4 Transfusion Medicine, Medical Faculty, Eberhard Karl University, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
5 University of Tübingen, Department of Internal Medicine III, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
6 University of Crete Medical School, Department of Biochemistry, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437); University of Tübingen, Department of Vegetative and Clinical Physiology, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
7 University of Crete Medical School, Department of Biochemistry, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437)
8 University of Tübingen, Department of Ophthalmology, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447); Department Ophthalmology, Bionics and Vision, Henry Ford Hospital, Henry Ford, United States (GRID:grid.413103.4) (ISNI:0000 0001 2160 8953)
9 University of Tübingen, Department of Ophthalmology, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
10 University of Tübingen, Department of Vegetative and Clinical Physiology, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)